SENSEX
NIFTY
GOLD
USD/INR

Weather

image 18    C

Economy News

The Economic Times

Economy / The Economic Times

details

Delhi HC clears Zydus to sell biosimilar of BMS cancer drug Nivolumab

The Delhi High Court has permitted Zydus Lifesciences to produce and market a biosimilar cancer drug. This decision comes as the patent for the original drug, Nivolumab, nears its expiration. The court prioritized patient access to affordable treatment. Zydus can now proceed with its biosimilar, ZRC-3276, while maintaining sales records.

12 Jan 2026 11:10 am